Brian DeSchuytner - 05 Sep 2023 Form 4 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Role
SVP, COO and CFO
Signature
/s/ Alejandra Carvajal, as attorney-in-fact
Issuer symbol
MRSN
Transactions as of
05 Sep 2023
Net transactions value
$0
Form type
4
Filing time
07 Sep 2023, 17:51:07 UTC
Previous filing
18 Jan 2023
Next filing
17 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRSN Restricted stock unit Award $0 +50,000 $0.000000 50,000 05 Sep 2023 Common Stock 50,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the Issuer.
F2 The RSUs will vest on October 1, 2024, subject to the Reporting Person's continued service to the Issuer on such vesting date.